Gamida Cell Ltd (NASDAQ:GMDA)

0.3154
BATS BZX Real-Time Price
As of 12:57pm ET
 +0.0119 / +3.92%
Today’s Change
0.22
Today|||52-Week Range
2.51
-75.55%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$43.6M

Company Description

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Boston, MA.

Contact Information

Gamida Cell Ltd.
116 Huntington Avenue
Boston Massachusetts 02116
P:(713) 400-6400
Investor Relations:

Employees

Shareholders

Mutual fund holders8.15%
Individual stakeholders5.58%
Other institutional18.13%

Top Executives

Abigail L. JenkinsPresident, Chief Executive Officer & Director
Michele I. KorfinChief Operating & Commercial Officer
Mary Theresa CoelhoChief Financial & Accounting Officer
Ronit SimantovChief Medical & Scientific Officer
Yona GeffenVice President-Research & Development